
Abstract Background We report on an intensive primary care (IPC) program at the JPS Health Network (JPS) in Tarrant County, Texas, for super-utilizer patients. Methods The IPC team consisted primarily of a family physician and community health worker. From 2019 to 2022, the physician approached super-utilizer patients, defined as 4+ emergency department (ED) visits or 2+ inpatient visits in the previous six months, offering to provide 24/7 personal care. The main outcomes wereED visits and hospitalizations one year before/after the index visit. For the qualitative component, 10 patients of the IPC program and 4 members of the IPC care team were interviewed. Thematic analysis provided insight into patterns of meaning-making and understanding participants’ perspectives. Results One hundred and forty-three patients were seen by the IPC physician, 128 with 2+ encounters (IPC patients), and 15 with one encounter. The IPC patients had 12 ED visits per-person year in the preperiod and 9.6 in the postperiod (−20%); compared to the one encounter control group with 13 per-person year in the preperiod and 15.5 in the postperiod (+23%). Three themes were developed. The IPC team: (1) mitigated the effects of various social determinants of health; (2) rebuilt trust with the health system; and (3) provided flexible medication access, benefits, and minimized specialty referrals, hence minimizing challenges accessing care to improve navigation of the health systems. Conclusions The JPS IPC program likely reduced ED use through addressing social determinant challenges, rebuilding trust with the healthcare system, and establishing a flexible comprehensive primary care relationship, demonstrating the potential of IPC models.
Background Doctors need to balance benefits and harms of treatments to advise patients and enable shared decision-making, yet studies indicate general practitioners (GPs) may not be familiar with treatment effect sizes. In atrial fibrillation, national guidelines on anticoagulation recommend risk scoring tools, which do not provide details of the absolute effects. Objectives To determine if presenting absolute data on benefits and risks of anticoagulation in atrial fibrillation influences GPs' treatment recommendations. Methods One hundred and fifty-nine GPs and 93 GP trainees in South East England were recruited from conferences and via email invitations. Participants completed a questionnaire with three clinical scenarios of progressively lower stroke risk. They were randomized to receive either guideline recommended risk scores, or descriptions of absolute risk, then asked for their anticoagulation recommendation and to self-rate their recommendation strength. Results In this study, doctors were less likely to recommend anticoagulation when given absolute data compared to risk scores in all three scenarios (P < .0077, P < .0001, P < .0001). In scenario one and two, even those who recommended treatment rated their recommendation strength lower (P < .0001, P < .012). In scenario two and three, qualified GP's decisions were more likely to concord with guidelines than trainees when given risk scores (P < .0072, P < .023), but no significant differences were seen if informed of absolute risk. Conclusion Doctors should have ready access to both guidelines and absolute data to tailor their advice to individual patients. Care is needed in how information is presented to avoid discouraging evidence-based practice.
Background Shared decision making (SDM) is a core element of patient-centred care, aligning treatment decisions with patients' preferences and values. Primary care clinical pharmacists (PCCPs) are well positioned to support SDM within interprofessional teams. This study examined patients' experiences of SDM with PCCPs in British Columbia's Pharmacists in Primary Care Network (PCN) Program and factors associated with those experiences. Methods A cross-sectional survey was distributed to patients who completed an appointment with a PCCP between May 2022 and September 2023. Those who reported that a decision was made about their care completed the nine-item Shared Decision Making Questionnaire (SDM-Q-9). Linear regression with Box-Cox transformation identified demographic, psychological, and clinical factors associated with SDM-Q-9 scores. Subgroup analyses were conducted by age and appointment type. Results Of the 2714 patients invited, 823 responded, 630 were eligible, and 604 completed the SDM-Q-9. The median total score was 77.8 (IQR 62.2-91.1), indicating moderately strong agreement that SDM occurred. Unadjusted analyses showed higher SDM scores among patients aged <65 and those with in-person appointments. In adjusted models, demographic and clinical factors explained little variance (adjusted R-2 = 0.05), whereas psychological factors-such as expectations of the PCCP, understanding of medications, motivation to engage with community pharmacists, and overall experience-accounted for most variance (final adjusted R-2 = 0.39). Conclusion Patients reported high levels of SDM with PCCPs. Experiences were driven mainly by perceptions and beliefs rather than demographics or clinical complexity, suggesting PCCPs engage patients equitably and strengthen collaborative medication decision making.
Background Female urinary incontinence (UI) affects one in three women and is frequently managed suboptimally. The app-based treatment URinControl demonstrated cost-effectiveness. However, implementation in Dutch primary care is limited. This study aimed to identify key barriers to implementation and develop strategies to support the uptake of URinControl in primary care settings.Methods We conducted a cross-sectional survey among Dutch general practitioners (GPs), community pharmacists, and supporting personnel working in general practice or local pharmacies. Barriers were identified using the Consolidated Framework for Implementation Research (CFIR). Potential implementation strategies were selected using the CFIR-Expert Recommendations for Implementing Change (ERIC) matching tool.Results A total of 174 healthcare professionals completed the questionnaire. Key barriers from both GP and pharmacy perspectives included doubts about the relative advantage of the app, limited knowledge of urinary incontinence and the app, organizational constraints, and limited digital skills among patients. In pharmacies, additional barriers included limited opportunity to discuss UI and concerns about financing. Based on these findings, five implementation strategies were developed.Interpretation Effective implementation of an evidence-based digital app for urinary incontinence in primary care requires improved awareness, knowledge, and support for healthcare professionals, as well as better structural integration of digital health tools into routine practice. Broader policy and societal shifts toward acceptance of eHealth are also needed. We also translated barriers into five tailored, theory-informed strategies addressing clinician education, patient engagement, workflow integration, financing, and collaboration between general practice and community pharmacy settings across the Netherlands in routine care implementation. Urinary incontinence affects about one in three women and can have a major impact on daily life, yet many women do not receive the care they need. URinControl is a smartphone app that helps women manage urinary incontinence and has previously been shown to be an effective and cost-efficient treatment. However, it is not yet widely used in Dutch primary care.In this study, we asked general practitioners, community pharmacists, and their support staff about the challenges of introducing the app into routine care. A total of 174 healthcare professionals completed a questionnaire. The main barriers included limited knowledge about urinary incontinence and the app, uncertainty about the app's added value, organizational challenges, and concerns that some patients may lack the digital skills needed to use it. Pharmacists also reported limited opportunities to discuss urinary incontinence with patients and concerns about reimbursement.Based on these findings, we developed five practical strategies to support implementation. These focus on educating healthcare professionals, informing and supporting patients, integrating the app into everyday clinical practice, improving funding arrangements, and strengthening collaboration between general practices and community pharmacies. These strategies may help increase access to effective, evidence-based digital care for women with urinary incontinence.